SRC family kinase (SFK) inhibitor dasatinib improves the antitumor activity of anti-PD-1 in NSCLC models by inhibiting Treg cell conversion and proliferation
| Image |  |
|---|---|
| Description | scientific article published in March 2021 |
| Author/s |
author: Diego Serrano Sergio Ortiz Espinosa Juan José Lasarte Irati Garmendia Miriam Redrado Francisco Exposito Alfonso Calvo Ruben Pio |
| Publication date | March 2021 |
| Language | English |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |